The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
about
Crucial Role of Vitamin D in the Musculoskeletal SystemIntermittent parathyroid hormone improve bone microarchitecture of the mandible and femoral head in ovariectomized rats.Effect of acute pancreatitis on the risk of developing osteoporosis: A nationwide cohort studyEfficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trialOsteoporosis diagnosis in men: the T-score controversy revisited.Fragility fracture: recent developments in risk assessment.DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal WomenManagement of severe osteoporosis.Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study.Bone Density Screening and Re-screening in Postmenopausal Women and Older Men.Systemic lupus erythematosus and fractures.Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study.Backscatter-difference Measurements of Cancellous Bone Using an Ultrasonic Imaging System.Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatmentWrist bone mineral density utility in diagnosing hip osteoporosis in postmenopausal women.Osteoporosis: the evolution of a diagnosis.Adjuvant Endocrine Therapy and Bone Health in Breast Cancer.Appropriate models for novel osteoporosis drug discovery and future perspectives.Shen (Kidney)-tonifying principle for primary osteoporosis: to treat both the disease and the Chinese medicine syndrome.Trends and Determinants of Osteoporosis Treatment and Screening in Patients with Rheumatoid Arthritis Compared to Osteoarthritis.Osteoporosis in Crisis: It's Time to Focus on Fracture.Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.Preceding and subsequent high- and low-trauma fracture patterns-a 13-year epidemiological study in females and males in Austria.Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis.Genetics of osteoporosis: searching for candidate genes for bone fragility.Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro.Time trends in osteoporosis risk factor profiles: a comparative analysis of risk factors, comorbidities, and medications over twelve years.Results of a fracture liaison service on hip fracture patients in an open healthcare system.Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.Time to Clinically Relevant Fracture Risk Scores in Postmenopausal Women.3-D bone models to improve treatment initiation among patients with osteoporosis: A randomised controlled pilot trial.Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis: PDGF-BB mediated by estradiol in women.Agreement between calcaneal quantitative ultrasound and osteoporosis self-assessment tool for Asians in identifying individuals at risk of osteoporosis.Duration of anti-resorptive therapy for osteoporosis.Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.Prevalence and predictors of asymptomatic vertebral fractures in inflammatory myositis.
P2860
Q26748795-F65F7973-7AC9-4904-9029-4B0A694A69A1Q33602111-82DFD5A4-CAE2-485F-B36C-55584182224CQ33788364-1C122023-D5AA-48E2-93D5-576997AB38F2Q34375420-04C70F4D-0F5F-420B-A338-ADEEE9CDE540Q34763893-F9FF59CA-82B3-4D7B-B986-9B1A28B19AF9Q35039567-D35F4019-E0D3-4092-9773-2EB24229A452Q35572053-16A4CE60-1BAF-4873-AEC3-E4EDEC315B41Q35852252-33E70743-04BF-4418-823B-120E59BD6E3BQ36190846-76375CB5-1A4A-4B5D-B170-B8356B575836Q36217631-E05F0BE1-C883-4EAC-89C2-E693E335CB04Q36246074-272EC2EC-444B-4839-A36E-3769406F0CEBQ36339797-D8A57A8C-835D-4CF4-B93E-407D70538312Q36734564-4A900174-AF6C-48AB-ADE3-C463C8AE48D9Q37549106-97B04E60-D4D7-4CBA-8EA3-966F2C4A304EQ37632124-2FEE3210-EC36-4680-AD11-651C834703D7Q38400152-2C8A4BFD-5B79-4214-82CF-C4178D1FD41AQ38553766-7F33D942-684F-4185-BAD6-3D525EBA946EQ38570326-C297F0BE-5AF6-4D54-BEEF-C95A5F765466Q38598245-262CCA2E-495A-4181-B4E5-07776A7BD72AQ38644029-A3453642-FE12-4D33-B2BD-9A9F4D1C34A8Q38677489-1A3951EE-FC75-4AB9-92C3-1ABAC160FE3FQ38698223-84E74388-82EE-41B9-A390-38B284A3DE49Q38764108-2B9A9DBB-C478-47F6-88AF-AB9C58109BE3Q38793382-D5296A0C-B685-4865-B52A-97BCC8C59605Q38830479-8F7F2D2C-2FAA-4CFB-96E3-15416DEFC1A4Q38973074-FD3A802E-D874-4076-BB55-05D44A66DB01Q39103062-567A2CA8-1E7D-4FE1-B73B-EBB7418A1601Q39177137-0B703D14-C63D-480C-AF21-9B3D62C4D386Q39654135-4E79F904-DEE0-4A2E-AA32-D2366B142BD9Q39767213-04EEAAE8-DA0F-459F-8FBE-FAAE54CADC80Q39980203-4D01EE1E-4705-44F7-ABEB-176DFC82FA7CQ40010387-23587973-E2DE-4640-A73A-3688FD146639Q40296309-7848E7BE-2597-488D-81CE-2EFFF2B5F994Q40379928-3B306457-0C88-4375-990F-B96070B3BDF1Q40961666-89FF5024-38D6-4923-AD97-CE6D26F39092Q41836904-D4904334-514F-451E-897E-E188D528800AQ42701533-CE8F4612-4369-44BF-B1A7-79C63DC26373Q45020081-55D94665-2D94-4BE3-BD99-949DFEB9CB88Q47136618-00E42A13-C531-418F-BB25-9119F9365E57Q47191067-AE31F757-F969-4C8D-BE3D-6ECF02C2167D
P2860
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical diagnosis of oste ...... Health Alliance Working Group.
@en
The clinical diagnosis of oste ...... Health Alliance Working Group.
@nl
type
label
The clinical diagnosis of oste ...... Health Alliance Working Group.
@en
The clinical diagnosis of oste ...... Health Alliance Working Group.
@nl
prefLabel
The clinical diagnosis of oste ...... Health Alliance Working Group.
@en
The clinical diagnosis of oste ...... Health Alliance Working Group.
@nl
P2093
P2860
P1476
The clinical diagnosis of oste ...... Health Alliance Working Group
@en
P2093
B Dawson-Hughes
E S Orwoll
J Bilezikian
M Bolognese
P2860
P2888
P304
P356
10.1007/S00198-014-2655-Z
P407
P577
2014-02-28T00:00:00Z